<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="2098">
  <stage>Registered</stage>
  <submitdate>5/09/2008</submitdate>
  <approvaldate>5/09/2008</approvaldate>
  <nctid>NCT00748137</nctid>
  <trial_identification>
    <studytitle>Bolus Insulin Card Calculator Randomised Controlled Study</studytitle>
    <scientifictitle>Bolus Insulin Card Calculator Randomised Controlled Study</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>06/04/26/5.01</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Type 1 Diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - ezy-BICC dose calculation card
Other interventions - Fixed dose

Active Comparator: Fixed dose - Fixed meal size and fixed aspart insulin dose except for minor changes based on measured blood glucose. Detemir basal insulin.

Experimental: ezy-BICC dose calculation card - variable meal size with variable aspart insulin dose determined with use of individualised dose calculation card. Detemir basal insulin.


Treatment: devices: ezy-BICC dose calculation card
small laminated table lists the dose of insulin to administer based on BGL and carbohydrate to be consumed - individualised for each study subject

Other interventions: Fixed dose
Approach where study subject is prescribed a set amount of carbohydrate to eat each meal and set dose of rapid acting insulin. Minor modifications may be made if the measured BGL is out of target

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
    <interventioncode>Other interventions interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>24 hours BGL &gt; 8.3mmol/l (CGMS)</outcome>
      <timepoint>3 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>HbA1c</outcome>
      <timepoint>3 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Age 11 - 18 years old

          -  Currently using indvidual subcutaneous injections (not CSII)</inclusivecriteria>
    <inclusiveminage>11</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>18</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  HbA1c &gt; 9.5%

          -  Serious illness</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/03/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>150</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate>1/01/2011</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,QLD</recruitmentstate>
    <hospital>Gosford District Hospital - Gosford</hospital>
    <hospital>John Hunter Children's Hospital - Newcastle</hospital>
    <hospital>Sydney Children's Hospital - Sydney</hospital>
    <hospital>Mater Children's Hospital - Brisbane</hospital>
    <hospital>Royal Children's Hospital - Brisbane</hospital>
    <postcode>2915 - Gosford</postcode>
    <postcode>2305 - Newcastle</postcode>
    <postcode> - Sydney</postcode>
    <postcode> - Brisbane</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>John Hunter Children's Hospital</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Royal North Shore Hospital</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Sydney Children's Hospitals Network</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Royal Children's Hospital</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Lady Cilento Children's Hospital, Brisbane</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>NovoNordisk Pharmaceuticals</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>In pediatric patients with type 1 diabetes using subcutaneous injections; a randomised
      controlled trial comparing the effects of fixed carbohydrate exchanges and insulin doses to
      the use of variable size meals and insulin doses determined with a bolus insulin calculation
      card.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00748137</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Donald Anderson, FRACP</name>
      <address />
      <phone>61-2-49855634</phone>
      <fax />
      <email>donald.anderson@hnehealth.nsw.gov.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>